June 03, 2010 at 12:11 PM EDT
Drug Pipeline Pulse Check: Amgen Scores, AstraZeneca Hits Setbacks
AMGEN Inc. (AMGN) This week’s pipeline highlight is on Amgen, as the company received approval sooner than expected for its osteoporosis drug Prolia, in both the U.S. and in Europe. “The FDA approval, which came more than a month before the action date of July 25, is a major boost for Amgen,” wrote Zacks Investment Research analysts. Although [...]
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here